Posts
Overview Research Article published Journal of Innate Immunity May 12, 2022
3rd Annual Complement-based Drug Development Summit 2019, November 13-15, 2019 Boston, MA
Robert Jan Lamers (CEO) will be present at the 3rd Annual Complement-based Drug Development Summit 2019, November 13-15, 2019 Boston, MA
17th European Meeting On Complement in Human Disease, EMCHD 2019, Madrid, September 14 - 17, 2019
Prof. Frank Baas (CSO) as well as Robert Jan Lamers (CEO) will be present at the 17th European Meeting On Complement in Human Disease, September 14 - 17, 2019, Madrid, Spain.
Bio-Europe Spring 2019, March 25-27, Vienna
Robert Jan Lamers (CEO) will be present at the Bio Europe Spring 2019 in Vienna, March 25-27.
Complement-based Drug Development Summit 2018, November 13-15, Boston
Prof. Frank Baas (CSO) will speak at the Complement-based Drug Development Summit 2018, November 13-15 in Boston. Prof. Frank Baas (CSO) as well as Robert Jan Lamers (CEO) will be present at this summit.
27th International Complement Workshop 2018, September 16-21, Sante Fe
Prof. Frank Baas (CSO) will present a poster on the 27th International Complement Workshop 2018, September 16-21 in Sante Fe, New Mexico. Both Prof. Frank Baas (CSO) and Robert Jan Lamers (CEO) will be present.
Alexion and Complement Pharma Announce Partnership to Co-Develop Pre-Clinical Complement Inhibitor for Neurodegenerative Disorders, June 2018
Complement Conference, London March 2018
Complement Pharma's CSO Prof. Frank Baas will present at the Complement Conference March 20-21 2018 in London.
JP Morgan Healthcare Conference, January 2018
Complement Pharma will be present at the JP Morgan Healthcare Conference, Januar 2018, San Francisco.
Michailidou et al. Glia 2017
Complement C3 on Microglial Clusters in Multiple Sclerosis Occur in Chronic but Not
Acute Disease: Implication for Disease Pathogenesis
Michailidou et al -2015- Annals of Neurology
Complement C1q-C3–Associated Synaptic Changes in Multiple Sclerosis Hippocampus
Michailidou et al. Frontiers in Neuroscience 2015
Activation of endogenous neural stem cells for multiple sclerosis therapy
Read more »